Isoflurane is a general anesthetic indicated for induction and maintenance of general anesthesia. It is available as inhalation solution and inhalant. MedsAcross supplies Isoflurane for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
FORANE (isoflurane, USP) may be used for induction and maintenance of general anesthesia. Adequate data have not been developed to establish its application in obstetrical anesthesia. FORANE, a general anesthetic, is an inhalation agent indicated for induction and maintenance of general anesthesia.
Source: US FDA prescribing information
• FORANE should be administered only by persons trained in the administration of general anesthesia. FORANE should only be delivered using a vaporizer specifically designed and designated for use with isoflurane. • The administration of general anesthesia must be individualized and titrated based on the patient’s age and clinical status.
Source: US FDA prescribing information
FORANE is contraindicated in patients: • in whom general anesthesia is contraindicated. • with known sensitivity to FORANE or to other halogenated agents. • with known or suspected genetic susceptibility to malignant hyperthermia. • with a history of confirmed hepatitis due to a halogenated inhalational anesthetic or a history of unexplained moderate to severe hepatic dysfunction (e.g., jaundice associated with fever and/or eosinophilia) after anesthesia with isoflurane or other halogenated inhalational anesthetics. • Patients in whom general anesthesia is contraindicated. • Patients with known sensitivity to FORANE or other halogenated agents.
Source: US FDA prescribing information
• Malignant Hyperthermia: Malignant hyperthermia may occur, especially in individuals with known or suspected susceptibility based on genetic factors or family history. Discontinue triggering agents, administer intravenous dantrolene sodium, and apply supportive therapies. • Perioperative Hyperkalemia: Perioperative hyperkalemia may occur. Patients with latent or overt neuromuscular disease, particularly with Duchenne muscular dystrophy, appear to be most vulnerable. Early, aggressive intervention is recommended. • Hepatic Reactions: May cause sensitivity hepatitis in patients sensitized by previous exposure to halogenated anesthetics. Approach repeated anesthesia with caution. • Hypersensitivity Reactions: Allergic-type hypersensitivity reactions, including anaphylaxis, have been reported with FORANE.
Source: US FDA prescribing information
Most common adverse reactions (incidence ≥ 5%) are agitation, cough, breath holding, nausea, chills/shivering, vomiting, laryngospasm, delirium.
Source: US FDA prescribing information
• Concomitant use of N 2 O and/or opioids reduces the MAC of FORANE. Adjust dose accordingly. • FORANE decreases the doses of neuromuscular blocking agents required. Adjust dose accordingly.
Source: US FDA prescribing information
Storage Store at room temperature 15°C - 30°C (59°F - 86°F). Isoflurane contains no additives and has been demonstrated to be stable at room temperature for periods in excess of five years.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
5 presentations of Isoflurane, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Isoflurane 1 mL/mL inhalation solutionInhalationGeneric name | — | US FDA | Available on request |
| Forane 1 mL/mL inhalantInhalation | Baxter Healthcare | US FDA | Available on request |
| Isoflurane, (Volatile for Inhalation) 100 mL/100 mL inhalation solutionInhalation | Mullan Pharmaceutical | US FDA | Available on request |
| Terrell 1 mL/mL inhalation solutionInhalation | Piramal Critical CareIndia | US FDA | Available on request |
| Terrell 1 mL/mL inhalation solutionInhalation | Piramal Critical CareIndia | US FDA | Available on request |
3 brand names across 1 markets.
United States
Indian manufacturers are highlighted.
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 18 December 1979 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Conditions linked to Isoflurane in public data. This is not a list of approved uses, see the clinical information.
Yes, on request. MedsAcross lists 5 presentations of Isoflurane and sources them for licensed hospitals, importers and physicians against valid import documents. Indian manufacturers include Piramal Critical Care.
The catalogue lists 3 brand names for Isoflurane, including Forane, Isoflurane, (Volatile for Inhalation), Terrell.
Yes. The US FDA first approved Isoflurane on 18 December 1979, according to Drugs@FDA.
No listed presentation of Isoflurane is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Isoflurane is classified under ATC code N01AB06 (Isoflurane).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.